Pure Global

High-pressure coronary artery spasm (non-responsive) - Vietnam Registration 2402647ĐKLH/BYT-HTTB

Access comprehensive regulatory information for High-pressure coronary artery spasm (non-responsive) in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402647ĐKLH/BYT-HTTB and manufactured by CÔNG TY CỔ PHẦN NHÀ MÁY TRANG THIẾT BỊ Y TẾ USM HEALTHCARE. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN NHÀ MÁY TRANG THIẾT BỊ Y TẾ USM HEALTHCARE.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2402647ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2402647ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

High-pressure coronary artery spasm (non-responsive)
VN: Bóng nong mạch vành áp lực cao (không đáp ứng)
Risk Class TTBYT Loại D

Registration Details

2402647ĐKLH/BYT-HTTB

000.00.04.G18-221221-0019

Theo theo phụ lục

Theo phụ lục

Company Information

CÔNG TY CỔ PHẦN NHÀ MÁY TRANG THIẾT BỊ Y TẾ USM HEALTHCARE

Technical Details

NOTRIX, a high-pressure coronary angioplasty balloon (non-responsive), is used for patients with symptoms of chronic myocardial ischemia due to new or re-narrowed coronary artery stenosis, as well as for the dilatation of the coronary artery and/or the stenotic segments of the coronary artery or vein bridges. In addition, the balloon angioplasty aims to facilitate the expansion of the coronary artery lumen and/or the stenotic segments of the coronary artery or vein bridges after stent placement, thereby enhancing the apposition of the stent to the arterial wall.

Dates and Status

Oct 02, 2024